The US Food and Drug Administration (FDA) has approved W L Gore & Associates' Conformable GORE TAG Thoracic Endoprosthesis to treat traumatic aortic transections occured in the descending thoracic aorta.
The GORE TAG Thoracic Endoprosthesis is delivered via catheter and inserted into the femoral artery through a small incision in the groin and is guided up the leg artery through the abdomen into the chest and to the site of the transection.
The device is available in diameters of 21-45 mm, allowing for the treatment of patients with aortic diameters of 16-42 mm.
Tapered device configurations are also available in the Conformable GORE TAG Thoracic Endoprosthesis.
Gore Aortic Business Leader David Abeyta said the Conformable GORE TAG Device provides an optimal fit and maximum conformability for each patient’s anatomy.
GORE said there is an ongoing US trial investigating Thoracic Endoprosthesis use for the treatment of acute dissection.